Reglan Failure-To-Warn Claims Not Preempted, NJ Court Says
The New Jersey Appellate Division preserved patients' allegations that manufacturers of generic Reglan failed to adequately warn about neurological risks because the companies dragged their feet in updating the digestion medication's...To view the full article, register now.
Already a subscriber? Click here to view full article